The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer
Neil J. Shah(Memorial Sloan Kettering Cancer Center), William Oh(Eunice Kennedy Shriver National Institute of Child Health and Human Development), George Mellgard(Memorial Sloan Kettering Cancer Center), Jessica E. Hawley(Columbia University Irving Medical Center), Michael J. Morris(Dana-Farber Cancer Institute), Jones T. Nauseef(Cornell University), Xiaobo Zhong(Icahn School of Medicine at Mount Sinai), Benjamin A. Gartrell, Himanshu Joshi(Icahn School of Medicine at Mount Sinai), Victor Adorno Febles(VA NY Harbor Healthcare System), Philip W. Kantoff(Convergent Science (United States)), Bobby Chi-Hung Liaw(Icahn School of Medicine at Mount Sinai), Panagiotis J. Vlachostergios(NewYork–Presbyterian Hospital), Vaibhav G. Patel(Arvinas (United States)), Luis A. Pina(Columbia University Irving Medical Center), Daniel H. Kwon(Harvard University), David A. Green(Columbia University), David R. Wise, Franklin W. Huang(Cancer Research Institute), Qian Qin(Icahn School of Medicine at Mount Sinai), Emily Lin(Montefiore Medical Center), Scott T. Tagawa(Cornell University)
Cited by 11
Related Papers
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
|New England Journal of Medicine|2010|5.5k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Whole-Body Hypothermia for Neonates with Hypoxic–Ischemic Encephalopathy
|New England Journal of Medicine|2005|2.8k
Gene expression correlates of clinical prostate cancer behavior
|Cancer Cell|2002|2.5k